Panacos Pharmaceuticals, Inc. Stock Other OTC
Equities
PANC
US69811Q1067
Biotechnology & Medical Research
Financials (USD)
Sales 2006 | 284K | Sales 2007 | 180K | Capitalization | 42.29M |
---|---|---|---|---|---|
Net income 2006 | -38M | Net income 2007 | -37M | EV / Sales 2006 | 504 x |
Net cash position 2006 | 60.4M | Net cash position 2007 | 32.58M | EV / Sales 2007 | 53.9 x |
P/E ratio 2006 |
-5.32
x | P/E ratio 2007 |
-1.12
x | Employees | - |
Yield 2006 * |
-
| Yield 2007 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
1st Jan change | Capi. | |
---|---|---|
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |